EGFR mutation testing and first line treatment of patients with advanced NSCLC and positive EGFR mutation status: results from a German registry. 31. Mai 2011 Eberhardt, W., Thomas, M., Graf von der Schulenburg, J.-M., Dietel, M., Schirmacher, P., Gutendorf, P., Zirrgiebel, U., Schütte, W., 2011. EMCC / ESMO, European Multidisciplinary Cancer Congress, Stockholm (Poster 133), 664. REASON: A Registry for the Epidemiologic and Scientific evaluation of EGFR mutation status in newly diagnosed NSCLC patients stage IIIB/IV. Dietel, M., Schütte, W., Thomas, M., Eberhardt, W., Graf von der Schulenburg, J.-M., Schirmacher, P., 2011. Weiterlesen Survival and palliative treatment course of colorectal cancer patients in German outpatient centres. Data from the clinical registry – TKK Registry. Freier, W., Rauh, J., Kindler, M., Jänicke, M., Marschner, N., 2011. Onkologie 34 (suppl 6)(V643), 189. doi:10.1159/000333303 Abstract… Weiterlesen